Hiroki Itoh

5PUBLICATIONS
18CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 24, 2026
Search for Novel Biomarkers to Predict Cytochrome P450 2C19 Activity Using Untargeted Metabolomics of Human Plasma.

|Aug 27, 2026
Risk Assessment of Neutropenia Based on Exposure Information Without Plasma Concentration Measurement in Pemetrexed-Platinum-Based Chemotherapy: A Modeling Approach Using Real-World Clinical Data.

|Jun 15, 2026
Association between anamorelin therapy and renal function in patients with cancer cachexia: a propensity score-matched retrospective study.

|Apr 28, 2025
Clinical relevance of immune checkpoint inhibitors for the analgesic effect of opioids: A retrospective propensity score analysis.

Takahiro Sumimoto, Ryota Tanaka, Yuko Murakami

|Mar 17, 2025
Impact of Cancer Cachexia Progression on OATP1B1 Transport Activity: Quantitative Analysis Using Coproporphyrin-I as an Endogenous Biomarker.

Takahiro Sumimoto, Ryota Tanaka, Yosuke Suzuki

Pageof 1

Frequent Collaborators

5 joint publications

Ryota Tanaka

4 joint publications

Ryosuke Tatsuta

3 joint publications

Takahiro Sumimoto

1 joint publications

Yosuke Suzuki